Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS)

@EBRheum There were some red flags in the prediction modelling as taught to us by @f2harrell (eg, stepwise selection based on p-values, dichotomising). I don’t how much #StatsTwitter would recommend the model. https://t.co/x2VOLkZdSY

RT @wabautistam: There is still room to improve methotrexate prescription in #rheumatoidarthritis https://t.co/RGaFLER0Qf

There is still room to improve methotrexate prescription in #rheumatoidarthritis

Are we good at prescribing and handling methotrexate for Rheumatoid Arthritis❓ https://t.co/gmF2He3kyv Up to 43% primary non responders. That's a huge failure rate❗❗❗ @ArthritisRes @BioMedCentral https://t.co/b50MTglcCH